The INTO? Study: Report of Results

The INTO? study was a cross-sectional survey of gay and bisexual men (GBM) in Australia conducted between December 2019 and March 2020. INTO? examined recent sexual and drug use events, with a focus on how biomedical HIV prevention methods may affect the negotiation of sex and drug use practices. Focusing on specific events rather than behaviour over a period of time can be useful to understand the complexities and specifics of intentions, behaviours, and disclosure of HIV status as individuals negotiate sex with different partners.

Key findings

Among non-HIV-positive respondents, 22.3% reported not currently using PrEP and had anal sex without a condom with a casual partner in the last 6 months.
Among participants who had casual sex in the last 6 months, 17.6% reported having a ‘no condoms plus drug use’ event, 52.9% reported having a ‘no condoms plus no drug use’ event, 3.1% reported ‘condoms plus drug use’ event and 33.6% reported having a ‘condoms plus no drug use’ event.
Among all participants ‘drug use plus no sex’ was reported by 16.8% of participants.
79.6% of ‘no condoms plus drug use’ events and 65.2% of ‘no condoms plus no drug use’ events were covered by either pre-exposure prophylaxis (PrEP) or treatment as prevention (TasP).

The INTO? Study: Report of Results 1.94 MB pdf

Report contact